| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/2007 | US7176360 Transgenic plants with traits such as herbicide resistance, insect resistance and disease resistance |
| 02/13/2007 | US7176359 Soybean cultivar 90046112 |
| 02/13/2007 | US7176358 Soybean cultivar 90897327 |
| 02/13/2007 | US7176357 Transgenic or hybrid crops has herbicide resistance, insect resistance and disease resistance; cross breeding, genetic engineering, tissue culture |
| 02/13/2007 | US7176356 Soybean variety XB19U04 |
| 02/13/2007 | US7176355 Ribosomal RNA regulatory sequences for use as tools in controlling heterologous gene expression; chloroplast transcription modulating element; tissue engineering |
| 02/13/2007 | US7176354 Genes encoding sulfate assimilation proteins |
| 02/13/2007 | US7176353 Genes encoding sulfate assimilation proteins |
| 02/13/2007 | US7176352 Enhancing genetic transformation by incubating the Lemnaceae plant tissue with the Agrobacterium cells in a medium contains caffeine; improve nutritional quality, disease resistance |
| 02/13/2007 | US7176351 Potatoes having an increased yield of starch per plant body and method for producing the same |
| 02/13/2007 | US7176350 Method for controlling ratio of proteins/lipids in crop seeds |
| 02/13/2007 | US7176349 Production of polyhydroxyalkanoate in plants |
| 02/13/2007 | US7176348 Cocoa polypeptides and their use in the production of cocoa and chocolate flavor |
| 02/13/2007 | US7176347 Vegetative growth specific promoter and transgenic plant obtained with the same |
| 02/13/2007 | US7176304 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery |
| 02/13/2007 | US7176303 Modulation of STAT5 expression |
| 02/13/2007 | US7176302 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is |
| 02/13/2007 | US7176301 Nitrate inducible promoter |
| 02/13/2007 | US7176300 Avian lysozyme promoter |
| 02/13/2007 | US7176299 Compounds |
| 02/13/2007 | US7176298 Polynucleotides encoding metal ion affinity peptides and related products |
| 02/13/2007 | US7176294 Transcription factor, BP1 |
| 02/13/2007 | US7176288 Human coagulation factor VII variants |
| 02/13/2007 | US7176287 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins |
| 02/13/2007 | US7176286 Antigen fragments for the diagnosis of Toxoplasma gondii |
| 02/13/2007 | US7176285 Ligands for human protein histidine phosphatase (PHP1); identifying agonists and antagonists and treating conditions associated with PHPIP-120 imbalance with the identified compounds; cardiovascular disorders; autism; schizophrenia; antiarthritic and -carcinogenic agents; Bardet-Beidl Syndrome; anemia |
| 02/13/2007 | US7176283 Protease-activated receptor 3 and uses thereof |
| 02/13/2007 | US7176280 Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use |
| 02/13/2007 | US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents |
| 02/13/2007 | US7176190 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds |
| 02/13/2007 | US7176187 Fusion proteins based upon somatostatin receptors |
| 02/13/2007 | US7176186 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176178 Protein H and its fragments/derivatives are capable of interacting with nucleophosmin/B23, actin, NPM/B23, protein SET or hnRNP A2/B1 |
| 02/13/2007 | US7176029 Cloning and/or sequencing vector |
| 02/13/2007 | US7176028 Generating expression vector containing conditional mutation and transfer and expression in eschrichia; genetic engineering and replicon propagation |
| 02/13/2007 | US7176027 Genes and regulatory DNA sequences associated with stress-related gene expression in plants and methods of using the same |
| 02/13/2007 | US7176026 Expression of the nucleic acid sequence which codes a protein kinase stresss related polypeptide in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant; genetic engineering |
| 02/13/2007 | US7176025 Methods for generating double stranded DNA comprising a 3′ single stranded portion and uses of these complexes for recombination |
| 02/13/2007 | US7176021 Mutant cells with altered sialic acid |
| 02/13/2007 | US7176020 Detection and monitoring anticarcinogenic agents; obtain tissue, infect with cancer cells, incubate with test compound, monitor antiproliferative activity |
| 02/13/2007 | US7176019 For modulating NF- kappa B signaling |
| 02/13/2007 | US7176013 Serine protease variant for use in diagnosis, prevention and treatment of cardiovascular disorders |
| 02/13/2007 | US7176012 Carboxypeptidase of cocoa |
| 02/13/2007 | US7176010 Encoded amino acid sequences, DNAs encoding the proteins, recombinant vectors, culturing, drugs comprising the proteins or DNAs, antibodies, drug screening, for arteriosclerosis, hyperlipidemia, obesity or mellitus diabetes |
| 02/13/2007 | US7176009 Sucrose phosphate synthase |
| 02/13/2007 | US7176007 RecA mutants |
| 02/13/2007 | US7176006 Comprises nucleotide sequences coding hydrolase for prodrug therapy; drug screening; drug delivery; detoxification |
| 02/13/2007 | US7176005 Generating hydrogen gas cleanly via propagation/culturing algae mutant for sulfate permease activity; pollution control and enenrgy |
| 02/13/2007 | US7176004 Circular site-directed mutagenesis |
| 02/13/2007 | US7176003 Subjecting a nucleic acid sample to a plurality of amplification reactions to amplify the segments, whrein the time of extension phase in each reaction is varied, monitoring progress of amplification, determing minimum time required |
| 02/13/2007 | US7176000 Fluorescent fusion protein for use as diagnostic tool in genetic engineering; reporter compounds |
| 02/13/2007 | US7175999 Identifying nucleotide sequences which code fat metabolism regulator protein (lpo-4)s for preventing and treating obesity and eating disorders |
| 02/13/2007 | US7175998 Stable Acanthamoeba protein expression systems |
| 02/13/2007 | US7175997 BMP-11 compositions |
| 02/13/2007 | US7175984 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 02/13/2007 | US7175983 Adapter-directed display systems |
| 02/13/2007 | US7175982 Method for the characterization of nucleic acid molecules involving generation of extendible upstream DNA fragments resulting from the cleavage of nucleic acid at an abasic site |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | US7175840 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 02/13/2007 | CA2298400C .beta.-fructofuranosidase gene |
| 02/13/2007 | CA2290707C Apolipoprotein e transgenic animals and assay methods |
| 02/13/2007 | CA2219962C C3 plants expressing photosynthetic enzyme of c4 plants |
| 02/13/2007 | CA2177959C Homologous recombination antibody expression system for murine cells |
| 02/13/2007 | CA2165781C Process for producing relaxin |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/12/2007 | CA2553115A1 Modulation of peroxisome proliferation-activated receptors |
| 02/08/2007 | WO2007016591A2 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/08/2007 | WO2007016566A2 Production of reprogrammed cells with restored potential |
| 02/08/2007 | WO2007016507A2 Multivalent rna nanoparticles for delivery of active agents to a cell |
| 02/08/2007 | WO2007016488A2 Analysis of encoded chemical libraries |
| 02/08/2007 | WO2007016319A2 Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp |
| 02/08/2007 | WO2007016276A2 Marker-free plant transformation |
| 02/08/2007 | WO2007016250A1 Method of purifying protein |
| 02/08/2007 | WO2007016221A2 Hyaluronan synthases and methods of making and using same |
| 02/08/2007 | WO2007015945A2 Development of novel germplasm using segregates from transgenic crosses |
| 02/08/2007 | WO2007015935A2 Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy |
| 02/08/2007 | WO2007015782A1 Molecular variant fibrinogen fusion proteins |
| 02/08/2007 | WO2007015771A2 Composition and method for introduction of rna interference sequences into targeted cells and tissues |
| 02/08/2007 | WO2007015638A2 Methods and means for controlling the endocytosis and subsequent degradation of a cell surface protein |
| 02/08/2007 | WO2007015569A1 Method for prediction of the efficacy of vascularization inhibitor |
| 02/08/2007 | WO2007015557A1 Novel artificial base pair and use thereof |
| 02/08/2007 | WO2007015546A1 Mesenchymal stem cell inducer, tissue regeneration promoter and method of preparing mesenchymal stem cell |
| 02/08/2007 | WO2007015540A1 Cytotoxic t-cell epitope peptide and use thereof |
| 02/08/2007 | WO2007015527A1 tRNA SYNTHESIS METHOD, NUCLEIC ACID, AMINOACYL tRNA SYNTHESIS METHOD, AND PROCESS FOR PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN |
| 02/08/2007 | WO2007015511A1 D-amino acid oxidase, and method for production of l-amino acid, 2-oxo acid or cyclic imine |
| 02/08/2007 | WO2007015502A1 Method for isolation of biopolymer by using re-circulating chromatography |
| 02/08/2007 | WO2007015470A1 Yeast host, transformant and method of producing foreign protein |
| 02/08/2007 | WO2007015459A1 Gene set for use in prediction of occurrence of lymph node metastasis of colorectal cancer |
| 02/08/2007 | WO2007015268A2 Antiporter gene from porteresia coarctata for conferring stress tolerance |
| 02/08/2007 | WO2007015267A2 Dehydrin gene from avicennia marina responsible for conferring salt tolerance in plants |
| 02/08/2007 | WO2007014991A1 Antibodies directed against a ldl receptor |
| 02/08/2007 | WO2007014977A1 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against leishmaniasis |
| 02/08/2007 | WO2007014844A2 Selection system for maize transformation |
| 02/08/2007 | WO2007014744A2 C-terminal tnf-family ligand (ctl) -prodrug |
| 02/08/2007 | WO2007014726A2 Thaumatin from transgenic barley |
| 02/08/2007 | WO2007014469A1 Hepatitis c antivirals |
| 02/08/2007 | WO2007014468A1 Development of pcr primers and primer mixtures for amplification of cnp60 target sequences |
| 02/08/2007 | WO2007014463A1 Nalp7-based diagnosis of female reproductive conditions |